vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and Zeo Energy Corp. (ZEO). Click either name above to swap in a different company.
ENANTA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($18.6M vs $18.6M, roughly 1.0× Zeo Energy Corp.). Zeo Energy Corp. runs the higher net margin — -10.8% vs -64.1%, a 53.3% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -0.4%). Zeo Energy Corp. produced more free cash flow last quarter ($2.3M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs -4.0%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
ENTA vs ZEO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $18.6M |
| Net Profit | $-11.9M | $-2.0M |
| Gross Margin | — | — |
| Operating Margin | -60.5% | -11.8% |
| Net Margin | -64.1% | -10.8% |
| Revenue YoY | 9.8% | -0.4% |
| Net Profit YoY | 46.4% | -360.9% |
| EPS (diluted) | $-0.42 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $18.6M | ||
| Q3 25 | $15.1M | $23.9M | ||
| Q2 25 | $18.3M | $18.1M | ||
| Q1 25 | $14.9M | $8.8M | ||
| Q4 24 | $17.0M | $18.6M | ||
| Q3 24 | $14.6M | $19.7M | ||
| Q2 24 | $18.0M | $14.8M | ||
| Q1 24 | $17.1M | $20.1M |
| Q4 25 | $-11.9M | $-2.0M | ||
| Q3 25 | $-18.7M | $-3.2M | ||
| Q2 25 | $-18.3M | $-2.4M | ||
| Q1 25 | $-22.6M | $-6.4M | ||
| Q4 24 | $-22.3M | $-435.3K | ||
| Q3 24 | $-28.8M | $-424.3K | ||
| Q2 24 | $-22.7M | $-277.8K | ||
| Q1 24 | $-31.2M | $-1.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 57.9% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 99.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 50.2% | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | — | — |
| Q4 25 | -60.5% | -11.8% | ||
| Q3 25 | -121.6% | -8.3% | ||
| Q2 25 | -103.2% | -15.8% | ||
| Q1 25 | -164.3% | -153.8% | ||
| Q4 24 | -138.8% | -6.0% | ||
| Q3 24 | -204.4% | -15.2% | ||
| Q2 24 | -134.6% | -18.0% | ||
| Q1 24 | -192.1% | -20.1% |
| Q4 25 | -64.1% | -10.8% | ||
| Q3 25 | -123.6% | -13.5% | ||
| Q2 25 | -99.7% | -13.3% | ||
| Q1 25 | -151.7% | -72.4% | ||
| Q4 24 | -131.4% | -2.3% | ||
| Q3 24 | -197.3% | -2.2% | ||
| Q2 24 | -126.1% | -1.9% | ||
| Q1 24 | -182.7% | -7.6% |
| Q4 25 | $-0.42 | — | ||
| Q3 25 | $-0.88 | — | ||
| Q2 25 | $-0.85 | — | ||
| Q1 25 | $-1.06 | $-0.48 | ||
| Q4 24 | $-1.05 | $1.11 | ||
| Q3 24 | $-1.36 | $-0.08 | ||
| Q2 24 | $-1.07 | $0.03 | ||
| Q1 24 | $-1.47 | $-1.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $6.1M |
| Total DebtLower is stronger | — | $79.1K |
| Stockholders' EquityBook value | $126.6M | $5.3M |
| Total Assets | $329.5M | $56.9M |
| Debt / EquityLower = less leverage | — | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | $6.1M | ||
| Q3 25 | $32.3M | $3.9M | ||
| Q2 25 | $44.8M | $68.7K | ||
| Q1 25 | $60.2M | $2.9M | ||
| Q4 24 | $84.3M | $5.6M | ||
| Q3 24 | $37.2M | $4.3M | ||
| Q2 24 | $35.8M | $5.3M | ||
| Q1 24 | $63.5M | — |
| Q4 25 | — | $79.1K | ||
| Q3 25 | — | $84.6K | ||
| Q2 25 | — | $642.8K | ||
| Q1 25 | — | $715.4K | ||
| Q4 24 | — | $787.7K | ||
| Q3 24 | — | $858.6K | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $748.8K |
| Q4 25 | $126.6M | $5.3M | ||
| Q3 25 | $64.7M | $-1.7M | ||
| Q2 25 | $79.3M | $-59.4M | ||
| Q1 25 | $93.5M | $-23.1M | ||
| Q4 24 | $111.8M | $-88.9M | ||
| Q3 24 | $128.8M | $-39.3M | ||
| Q2 24 | $148.9M | $-53.0M | ||
| Q1 24 | $166.1M | $-173.0M |
| Q4 25 | $329.5M | $56.9M | ||
| Q3 25 | $280.7M | $58.5M | ||
| Q2 25 | $301.0M | $46.2M | ||
| Q1 25 | $323.0M | $47.4M | ||
| Q4 24 | $348.6M | $61.0M | ||
| Q3 24 | $376.7M | $47.1M | ||
| Q2 24 | $398.8M | $49.1M | ||
| Q1 24 | $413.6M | $50.1M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $2.4M |
| Free Cash FlowOCF − Capex | $-11.8M | $2.3M |
| FCF MarginFCF / Revenue | -63.6% | 12.2% |
| Capex IntensityCapex / Revenue | 0.8% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | $-9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $2.4M | ||
| Q3 25 | $-6.5M | $-6.6M | ||
| Q2 25 | $17.5M | $-2.3M | ||
| Q1 25 | $-13.5M | $-2.3M | ||
| Q4 24 | $-16.8M | $3.5M | ||
| Q3 24 | $-10.4M | $162.2K | ||
| Q2 24 | $-14.8M | $-2.2M | ||
| Q1 24 | $-28.6M | $-10.2M |
| Q4 25 | $-11.8M | $2.3M | ||
| Q3 25 | $-7.9M | $-6.8M | ||
| Q2 25 | $17.4M | $-2.7M | ||
| Q1 25 | $-16.0M | $-2.6M | ||
| Q4 24 | $-25.5M | $3.4M | ||
| Q3 24 | $-19.4M | $116.5K | ||
| Q2 24 | $-21.3M | $-2.3M | ||
| Q1 24 | $-30.3M | $-10.4M |
| Q4 25 | -63.6% | 12.2% | ||
| Q3 25 | -52.5% | -28.6% | ||
| Q2 25 | 94.7% | -15.0% | ||
| Q1 25 | -107.4% | -30.0% | ||
| Q4 24 | -150.6% | 18.2% | ||
| Q3 24 | -132.5% | 0.6% | ||
| Q2 24 | -118.6% | -15.6% | ||
| Q1 24 | -177.5% | -51.5% |
| Q4 25 | 0.8% | 0.9% | ||
| Q3 25 | 9.6% | 1.0% | ||
| Q2 25 | 0.8% | 2.4% | ||
| Q1 25 | 17.0% | 4.2% | ||
| Q4 24 | 51.6% | 0.5% | ||
| Q3 24 | 61.3% | 0.2% | ||
| Q2 24 | 36.4% | 0.7% | ||
| Q1 24 | 9.8% | 1.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTA
Segment breakdown not available.
ZEO
| Nonrelated Party | $18.1M | 98% |
| Related Party | $432.1K | 2% |
